Procurement ID: 1322983 : Zp/44/TP/26 Delivery of the drug Obinutuzumab for a non‑commercial clinical trial under the experimental arm AVO‑CLL, funded by the Medical Research Agency within the framework of the project entitled “AVO‑CLL Study: A multicenter, randomized, open-label Phase 3 trial comparing the efficacy and safety of acalabrutinib in combination with obinutuzumab versus venetoclax in combination with obinutuzumab in the first-line treatment of newly diagnosed chronic lymphocytic leukemia.”

Specjalistyczny Szpital im. dr Alfreda Sokołowskiego